相关实验视频
Updated: May 8, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
706
血小板功能测试和基因定型用于复杂PCI患者的量身定制治疗
Athanasios Moulias1, Angeliki Papageorgiou1, Dimitrios Alexopoulos2
1Department of Cardiology, General University Hospital of Patras Patras, Greece.
US cardiology
|December 25, 2024
概括
优化复杂的穿皮冠状动脉干预 (PCI) 患者的双重抗血小板治疗 (DAPT) 是一个挑战. 本综述探讨了血小板功能测试和基因定型,以定制抗血小板治疗,并注意到目前的证据有限.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 使用阿司匹林和P2Y12抑制剂的双抗血小板疗法 (DAPT) 是标准的皮肤穿刺后冠状动脉干预 (PCI).
- 复杂PCI (C-PCI) 患者面临更高的缺血风险,使DAPT策略选择复杂化.
- 在C-PCI中平衡缺血和出血风险需要个性化的DAPT方法.
研究的目的:
- 批判性地评估血小板功能测试和基因定型的实用性,以定制C-PCI患者的DAPT.
- 审查目前关于个性化抗血小板疗法的证据,在这个特定的亚群中.
主要方法:
- 临床试验和研究的文献综述.
- 对C-PCI患者血小板功能测试和基因定型的证据分析.
- 对DAPT的治疗个性化策略的评估.
主要成果:
- 在PCI群体中对血小板功能测试和基因定型的现有试验显示了相互矛盾的和基本上中立的结果.
- 由于有限的专用研究,这些工具在C-PCI中优化DAPT的作用仍然不确定.
- 对DAPT强度和持续时间的个性化是C-PCI的一个不断发展的策略.
结论:
- 目前的证据不足以最终推血小板功能测试或基因定型用于指导C-PCI患者的DAPT.
- 需要进一步的专门研究来确定这些个性化方法的临床实用性.
- 在C-PCI中优化抗血小板治疗仍然是一个需要进一步研究的领域.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
388
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
388
Anticoagulant Drugs: Low-Molecular-Weight Heparins
532
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
532
Formation of the Platelet Plug
2.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
2.7K

